World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
75
Citations
36246
World Ranking
1948
National Ranking
953

Daniela Weiskopf publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Daniela Weiskopf sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 257 publications — 53rd percentile

53% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Daniela Weiskopf D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Daniela Weiskopf sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 75 D-Index — 61st percentile

61% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Daniela Weiskopf is affiliated with the La Jolla Institute For Allergy & Immunology in the United States. Their research focuses primarily within the field of Medicine, with a strong emphasis on Infectious Diseases and Immunology.

The subfields in which they have contributed include:

  • Infectious Diseases
  • Immunology
  • Public Health, Environmental and Occupational Health
  • Molecular Biology
  • Neurology

The key topics of their research encompass:

  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 Clinical Research Studies
  • Vaccines and Immunoinformatics Approaches
  • Mosquito-borne Diseases and Control
  • Immunotherapy and Immune Responses
  • Long-Term Effects of COVID-19
  • Vaccine Coverage and Hesitancy

Daniela Weiskopf's publications include recent papers focusing mainly on immune responses related to SARS-CoV-2 and COVID-19:

  • Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals (2020, Cell)
  • Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection (2021, Science)
  • Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity (2020, Cell)
  • Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans (2020, Science)
  • Phenotype and kinetics of SARS-CoV-2-specific T cells in COVID-19 patients with acute respiratory distress syndrome (2020, Science Immunology)

The frequent co-authors working with Weiskopf highlight collaborations with researchers in immunology and infectious diseases:

  • Alessandro Sette
  • Alba Grifoni
  • Shane Crotty
  • José Mateus
  • Ricardo da Silva Antunes

The venues where Weiskopf most frequently publishes are:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Frontiers in Immunology
  • Science Immunology
  • UNC Libraries
  • Cell

Best Publications

  • Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals.

    Alba Grifoni;Daniela Weiskopf;Sydney I. Ramirez;Sydney I. Ramirez;Jose Mateus

  • Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection.

    Jennifer M. Dan;Jennifer M. Dan;Jose Mateus;Yu Kato;Kathryn M. Hastie

  • Induction of autophagy by spermidine promotes longevity

    Tobias Eisenberg;Heide Knauer;Alexandra Schauer;Sabrina Büttner

  • Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity.

    Carolyn Rydyznski Moderbacher;Sydney I. Ramirez;Sydney I. Ramirez;Jennifer M. Dan;Jennifer M. Dan;Alba Grifoni

  • Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans.

    Jose Mateus;Alba Grifoni;Alison Tarke;John Sidney

  • The aging of the immune system

    Daniela Weiskopf;Birgit Weinberger;Beatrix Grubeck-Loebenstein

  • Properties of MHC Class I Presented Peptides That Enhance Immunogenicity

    Jorg J. A. Calis;Matt Maybeno;Jason A. Greenbaum;Daniela Weiskopf

  • The receptor binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients.

    Lakshmanane Premkumar;Bruno Segovia-Chumbez;Ramesh Jadi;David R. Martinez

  • Phenotype and kinetics of SARS-CoV-2-specific T cells in COVID-19 patients with acute respiratory distress syndrome.

    Daniela Weiskopf;Katharina S. Schmitz;Matthijs P. Raadsen;Alba Grifoni

  • SARS-CoV-2 vaccination induces immunological T cell memory able to cross-recognize variants from Alpha to Omicron

    Unknown

  • mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern.

    Rishi R. Goel;Mark M. Painter;Sokratis A. Apostolidis;Divij Mathew

  • T cells from patients with Parkinson’s disease recognize α-synuclein peptides

    David Sulzer;Roy N. Alcalay;Francesca Garretti;Lucien Cote

  • Comprehensive analysis of dengue virus-specific responses supports an HLA-linked protective role for CD8+ T cells

    Daniela Weiskopf;Michael A. Angelo;Elzinandes L. de Azeredo;John Sidney

  • T cell responses to SARS-CoV-2 spike cross-recognize Omicron

    Unknown

  • A Single-Dose Intranasal ChAd Vaccine Protects Upper and Lower Respiratory Tracts against SARS-CoV-2.

    Ahmed O. Hassan;Natasha M. Kafai;Igor P. Dmitriev;Julie M. Fox

  • Comprehensive analysis of T cell immunodominance and immunoprevalence of SARS-CoV-2 epitopes in COVID-19 cases.

    Alison Tarke;Alison Tarke;John Sidney;Conner K. Kidd;Jennifer M. Dan;Jennifer M. Dan

  • Impact of SARS-CoV-2 variants on the total CD4 + and CD8 + T cell reactivity in infected or vaccinated individuals.

    Alison Tarke;Alison Tarke;John Sidney;Nils Methot;Esther Dawen Yu

  • Imbalance of Regulatory and Cytotoxic SARS-CoV-2-Reactive CD4 + T Cells in COVID-19.

    Benjamin J. Meckiff;Ciro Ramírez-Suástegui;Vicente Fajardo;Serena J. Chee

  • Biology of immune responses to vaccines in elderly persons.

    Birgit Weinberger;Dietmar Herndler-Brandstetter;Angelika Schwanninger;Daniela Weiskopf

  • Cellular and humoral immune responses following SARS-CoV-2 mRNA vaccination in patients with multiple sclerosis on anti-CD20 therapy.

    Sokratis A. Apostolidis;Mihir Kakara;Mark M Painter;Rishi Raj Goel

  • Rapid induction of antigen-specific CD4 + T cells is associated with coordinated humoral and cellular immunity to SARS-CoV-2 mRNA vaccination.

    Mark M. Painter;Divij Mathew;Rishi R. Goel;Sokratis A. Apostolidis

  • Altered cellular and humoral immune responses following SARS-CoV-2 mRNA vaccination in patients with multiple sclerosis on anti-CD20 therapy.

    Sokratis A. Apostolidis;Mihir Kakara;Mark M Painter;Rishi Raj Goel

Frequent Co-Authors

Alessandro Sette
Alessandro Sette La Jolla Institute For Allergy & Immunology
Bjoern Peters
Bjoern Peters La Jolla Institute For Allergy & Immunology
Alba Grifoni
Alba Grifoni La Jolla Institute For Allergy & Immunology
John Sidney
John Sidney La Jolla Institute For Allergy & Immunology
Shane Crotty
Shane Crotty La Jolla Institute For Allergy & Immunology
Elizabeth J. Phillips
Elizabeth J. Phillips Vanderbilt University Medical Center
Simon Mallal
Simon Mallal Vanderbilt University Medical Center
Pandurangan Vijayanand
Pandurangan Vijayanand La Jolla Institute For Allergy & Immunology
Aravinda M. de Silva
Aravinda M. de Silva University of North Carolina at Chapel Hill
Eva Harris
Eva Harris University of California, Berkeley

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in expanding their expertise beyond immunology, several related online degree pathways offer promising career opportunities. Nursing professionals, for example, can explore specialized programs such as the best online pmhnp programs, which focus on psychiatric mental health nurse practitioner training with strong clinical placement rates. These programs are designed to prepare nurses for advanced roles in mental health care, complementing immunology knowledge in areas like autoimmune or inflammatory disorders.

Cost is often a significant factor in pursuing further education. Prospective students may find valuable options by exploring the cheapest psych np programs, helping reduce financial barriers while advancing clinical expertise related to immune system impacts on mental health.

For those aiming to understand the financial outlook in nursing, insights into dnp salary transparency can provide critical information on earning potentials across different regions, guiding long-term career planning.

Additionally, nurses interested in acute care can consider transitioning by obtaining an acute care certification for fnp. This pathway allows family nurse practitioners to expand their scope into critical care settings, intersecting with immunology through the treatment of severe infections and immune responses.

Best Scientists Citing Daniela Weiskopf

Trending Scientists

Recently Published Articles